<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> interference has been implicated in diverse biological process </plain></SENT>
<SENT sid="1" pm="."><plain>It is a powerful method for specific gene silencing which may also lead to promising novel therapeutic strategies </plain></SENT>
<SENT sid="2" pm="."><plain>The success of early studies of therapeutic RNAi in <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> has generated considerable interest on the development of RNAi as a potential therapy </plain></SENT>
<SENT sid="3" pm="."><plain>A number of recent patents have been published that deal with the use of siRNA as therapeutic tools for human diseases </plain></SENT>
<SENT sid="4" pm="."><plain>In this review, I will comment on some of the patents issued on siRNA-based strategies for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, ocular <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">diseases, cardiovascular</z:e> <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">disease, Alzheimer's</z:e> disease, <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, bone healing, and monogenic diseases such as <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo>, <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> or Huntingon's disease </plain></SENT>
<SENT sid="5" pm="."><plain>Progress in developing RNAi-based drugs and potential obstacles will also be discussed </plain></SENT>
</text></document>